Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covid‐19 vaccination in autoimmune rheumatic diseases: A multi‐center survey from southern India
Kavitha Mohanasundaram, Sham Santhanam, Raja Natarajan, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 9, pp. 1046-1052
Open Access | Times Cited: 24

Showing 24 citing articles:

Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis
Mahya Shabani, Parnian Shobeiri, Shadi Nouri, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
Kshitij Jagtap, R Naveen, Jessica Day, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 12, pp. 3838-3848
Open Access | Times Cited: 15
Self‐Reported Delayed Adverse Events and Flare Following COVID‐19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD‐2 Study
Syahrul Sazliyana Shaharir, Azmawati Mohammed Nawi, Theepa Nesam Mariamutu, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 10
Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis
Rossella Talotta
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 9
COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
Jih‐Jin Tsai, Li‐Teh Liu, Chun‐Hong Chen, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003038-e003038
Open Access | Times Cited: 9
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
R Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 7, pp. 2453-2463
Open Access | Times Cited: 15
Understanding Stakeholders’ Perspectives to Increase COVID‐19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions
Nnenna Ezeh, Greta Sirek, Sciaska N. Ulysse, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 12, pp. 2508-2518
Closed Access | Times Cited: 5
COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis
Sangeeta Dey, Yadlapalli S. Kusuma, Shashi Kant, et al.
Pathogens and Global Health (2023) Vol. 118, Iss. 2, pp. 182-195
Open Access | Times Cited: 5
Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2‐sample Mendelian randomization study
Liuliu Quan, Jiang-Shan Tan, Lu Hua, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 4, pp. 710-717
Closed Access | Times Cited: 4
Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study
Madhavi Eerike, Vijaya Prasanna Parimi, Anand Pyati, et al.
Journal of Rheumatic Diseases (2023) Vol. 31, Iss. 1, pp. 15-24
Open Access | Times Cited: 4
Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases
Vikas Gupta, Vikram Kumar Gupta, Navjot Bajwa, et al.
Journal of Family Medicine and Primary Care (2024) Vol. 13, Iss. 5, pp. 1904-1910
Open Access | Times Cited: 1
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry
B. Farisoğulları, Saskia Lawson‐Tovey, Kimme L Hyrich, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 11, pp. 1584-1595
Open Access | Times Cited: 1
Attitudes and factors affecting decision‐making regarding COVID‐19 vaccination among autoimmune rheumatic disease patients
Orathai Wantha, Ajanee Mahakkanukrauh, Kwankaew Tuydaung, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 4, pp. 751-758
Closed Access | Times Cited: 4
Corticosteroids and disease‐modifying antirheumatic drugs for coronavirus disease 2019 in patients with rheumatoid arthritis
Yuhan Chen, Yuan‐Ti Lee, Kevin Sheng‐Kai
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 7, pp. 1391-1392
Closed Access | Times Cited: 3
The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
Alfonso Gastélum Strozzi, Diana Elsa Flores‐Alvarado, Virginia Pascual‐Ramos, et al.
Rheumatology International (2023) Vol. 43, Iss. 7, pp. 1253-1264
Open Access | Times Cited: 3
COVID-19 Vaccination Hesitancy in Autoimmune Disease Patients: Policy Action and Ethical Considerations
Nardeen Shafik, Jennifer E. Akpo, Kristie C. Waterfield, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1283-1283
Open Access | Times Cited: 2
Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital
Naveena Mary Cherian, Dravya Anna Durai, Muhammed Jaisel, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2023) Vol. 11
Open Access | Times Cited: 2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS
Maria D. LaRusso, C. Abadía
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 5, pp. 361-367
Open Access | Times Cited: 2
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
Sakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 89-97
Closed Access | Times Cited: 2
COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China
Chen Chen, S. Huang, Linyu Geng, et al.
Rheumatology International (2023) Vol. 44, Iss. 4, pp. 703-713
Closed Access | Times Cited: 2
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access
Understanding COVID-19 vaccine hesitancy in vasculitis patients
Imama N. Butt, Charmaine van Eeden, Katharina Kovacs Burns, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Page 1

Scroll to top